Rheacell Gmbh & Co. Kg
Clinical trials sponsored by Rheacell Gmbh & Co. Kg, explained in plain language.
-
Stem cells may heal wounds in butterfly children: new trial
Disease control OngoingThis phase 3 trial tests whether a special type of stem cell (ABCB5+ MSCs) given through a vein can safely and effectively heal wounds in people with epidermolysis bullosa, a rare genetic condition that causes fragile, blistering skin. The study includes 91 participants with two …
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated May 26, 2026 11:30 UTC
-
Stem cell therapy offers hope for butterfly children with fragile skin
Disease control OngoingThis study tests a treatment made from special stem cells (ABCB5+ MSCs) given through an IV to people with epidermolysis bullosa, a rare disease that causes fragile, blistering skin. The main goal is to see if it safely helps close chronic wounds. The trial includes children as y…
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated May 26, 2026 11:09 UTC
-
New hope for hard-to-heal leg ulcers: cell therapy enters final testing
Disease control OngoingThis phase 3 trial tests a topical cell therapy called Allo-APZ2-CVU for chronic venous leg ulcers that haven't healed with standard care. About 250 adults with ulcers between 1 and 25 cm² are enrolled. The goal is to see if the treatment leads to complete wound closure lasting a…
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated May 08, 2026 12:03 UTC